loading
Lava Therapeutics Nv stock is traded at $1.62, with a volume of 122.59K. It is up +0.62% in the last 24 hours and up +1.89% over the past month. LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.61
Open:
$1.62
24h Volume:
122.59K
Relative Volume:
0.35
Market Cap:
$42.61M
Revenue:
$4.99M
Net Income/Loss:
$-28.29M
P/E Ratio:
-1.5388
EPS:
-1.0528
Net Cash Flow:
$-36.20M
1W Performance:
+9.46%
1M Performance:
+1.89%
6M Performance:
+17.39%
1Y Performance:
-19.00%
1-Day Range:
Value
$1.60
$1.63
1-Week Range:
Value
$1.44
$1.64
52-Week Range:
Value
$0.8502
$2.06

Lava Therapeutics Nv Stock (LVTX) Company Profile

Name
Name
Lava Therapeutics Nv
Name
Phone
31 6 3000 3035
Name
Address
YALELAAN 62, UTRECHT
Name
Employee
34
Name
Twitter
Name
Next Earnings Date
2025-03-28
Name
Latest SEC Filings
Name
LVTX's Discussions on Twitter

Compare LVTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LVTX
Lava Therapeutics Nv
1.62 38.67M 4.99M -28.29M -36.20M -1.0528
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.36 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
461.56 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.81 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
811.97 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
309.94 34.68B 4.56B -176.77M 225.30M -1.7177

Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-12-24 Downgrade Leerink Partners Outperform → Market Perform
Dec-11-24 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Oct-25-22 Initiated H.C. Wainwright Buy
Apr-19-21 Initiated JP Morgan Overweight
Apr-19-21 Initiated Jefferies Buy
Apr-19-21 Initiated SVB Leerink Outperform
View All

Lava Therapeutics Nv Stock (LVTX) Latest News

pulisher
09:47 AM

Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.July 2025 Gainers & Long-Term Safe Investment Ideas - newser.com

09:47 AM
pulisher
09:35 AM

Can LAVA Therapeutics N.V. hit a new high this monthJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com

09:35 AM
pulisher
06:32 AM

How LAVA Therapeutics N.V. stock valuations compare to rivalsEarnings Performance Report & Risk Managed Investment Entry Signals - newser.com

06:32 AM
pulisher
Oct 23, 2025

How LAVA Therapeutics N.V. (4PKB) stock expands through international marketsQuarterly Profit Summary & Verified Entry Point Signals - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Insider Selling: LAVA Therapeutics (NASDAQ:LVTX) Major Shareholder Sells $1,460,000.00 in Stock - Defense World

Oct 23, 2025
pulisher
Oct 23, 2025

Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsMarket Growth Report & Breakout Confirmation Trade Signals - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Heatmap analysis for LAVA Therapeutics N.V. and competitorsTrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

What indicators show strength in LAVA Therapeutics N.V.Quarterly Trade Review & Capital Efficient Trading Techniques - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

What analysts say about LAVA Therapeutics NV 4PKB stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in

Oct 22, 2025
pulisher
Oct 22, 2025

What drives LAVA Therapeutics NV stock priceEmerging Market Stocks & Zero-Cost Stock Research by Professionals - earlytimes.in

Oct 22, 2025
pulisher
Oct 22, 2025

Reversal indicators forming on LAVA Therapeutics N.V. stockEarnings Risk Report & Fast Momentum Entry Tips - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Is LAVA Therapeutics N.V. forming a reversal patternJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Price momentum metrics for LAVA Therapeutics N.V. explainedEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Historical volatility pattern of LAVA Therapeutics N.V. visualizedMarket Trend Summary & Entry Point Confirmation Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

LAVA Therapeutics N.V. stock prediction for this weekMarket Rally & Verified Short-Term Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Published on: 2025-10-21 15:08:21 - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Custom strategy builders for tracking LAVA Therapeutics N.V.2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Gilde healthcare sells LAVA Therapeutics (LVTX) shares for $4.2m By Investing.com - Investing.com UK

Oct 20, 2025
pulisher
Oct 20, 2025

Gilde healthcare sells LAVA Therapeutics (LVTX) shares for $4.2m - Investing.com India

Oct 20, 2025
pulisher
Oct 20, 2025

[Form 4] LAVA Therapeutics NV Insider Trading Activity - Stock Titan

Oct 20, 2025
pulisher
Oct 20, 2025

Shareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement - Morningstar

Oct 20, 2025
pulisher
Oct 19, 2025

LAVA Therapeutics N.V. recovery potential after sell offTrade Risk Report & Daily Profit Maximizing Tips - newser.com

Oct 19, 2025
pulisher
Oct 19, 2025

Analyzing net buyer seller activity in LAVA Therapeutics N.V.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com

Oct 19, 2025

Lava Therapeutics Nv Stock (LVTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Lava Therapeutics Nv Stock (LVTX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Cooperatieve Gilde Healthcare
10% Owner
Oct 16 '25
Sale
1.49
690,239
1,028,456
4,128,912
Cooperatieve Gilde Healthcare
10% Owner
Oct 14 '25
Sale
1.51
227,341
343,285
5,019,151
Cooperatieve Gilde Healthcare
10% Owner
Oct 13 '25
Sale
1.54
47,686
73,436
5,246,492
Cooperatieve Gilde Healthcare
10% Owner
Oct 10 '25
Sale
1.55
49,869
77,297
5,294,178
Cooperatieve Gilde Healthcare
10% Owner
Oct 09 '25
Sale
1.56
48,169
75,144
5,344,047
Cooperatieve Gilde Healthcare
10% Owner
Oct 08 '25
Sale
1.57
28,954
45,458
5,392,216
Versant Venture Capital VI, L.
10% Owner
Sep 19 '25
Sale
1.40
2,370,533
3,322,065
0
Versant Venture Capital VI, L.
10% Owner
Sep 19 '25
Sale
1.40
532,870
746,764
0
Versant Venture Capital VI, L.
10% Owner
Sep 17 '25
Sale
1.49
362,806
540,291
2,736,644
Versant Venture Capital VI, L.
10% Owner
Sep 18 '25
Sale
1.44
366,111
527,859
2,370,533
$37.21
price up icon 0.99%
$91.20
price up icon 2.14%
$29.80
price down icon 0.25%
$105.28
price up icon 0.51%
$160.37
price up icon 0.18%
biotechnology ONC
$309.94
price up icon 0.04%
Cap:     |  Volume (24h):